Samsara BioCapital GP, LLC

MLYS

Samsara BioCapital GP, LLC serves as an insider at Mineralys Therapeutics, Inc. (MLYS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

3 trades

$16.86M

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$16.86M

Companies Traded

MLYS, NGNE

Active Period

Feb 2024 – Mar 2025

3 total trades

Most Recent

Buy MLYS

Mar 17, 2025 · $8.10M

Samsara BioCapital GP, LLC's Insider Trading at Mineralys Therapeutics, Inc. (MLYS)

Buys

2 · $15.60M

Sells

0 · $0.00

Total Shares Bought

1,155,555

Total Shares Sold

MLYS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 17, 2025	Buy	600,000	$13.50	$8.10M	5,674,916
Feb 14, 2024	Buy	555,555	$13.50	$7.50M	5,074,916

Samsara BioCapital GP, LLC's Insider Trading at Neurogene Inc. (NGNE)

Buys

1 · $1.26M

Sells

0 · $0.00

Total Shares Bought

48,770

Total Shares Sold

NGNE Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 27, 2024	Buy	48,770	$25.83	$1.26M	1,717,127

Related Insiders

David Malcom Rodman

officer: Chief Medical Officer

MLYSSell · Jun 12, 2026

Christine Mikail Cvijic

officer: President and CFO

NGNESell · May 8, 2026

Jon Congleton

director, officer: Chief Executive Officer

MLYSSell · Apr 15, 2026

Daphne Karydas

Director

MLYSSell · Apr 2, 2026

RA CAPITAL MANAGEMENT, L.P.

director

MLYSBuy · Mar 31, 2026

Julie Jordan

officer: Chief Medical Officer

NGNESell · Mar 30, 2026

Rachel McMinn

director, officer: Chief Executive Officer

NGNESell · Mar 30, 2026

Stuart Cobb

officer: Chief Scientific Officer

NGNESell · Mar 17, 2026

Explore More Insider Trading Data

MLYS Insider Trading Activity

View all insider trades at Mineralys Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity